BBH : VanEck Vectors Biotech ETF

BBH is a Sector Equity Market Healthcare with LOW fees.

BBH

VanEck Vectors Biotech ETF

FI Score

64 /100

Diversification Rating

10 /10

Expense Ratio Rating

9 /10

Expense Rating

7 /10

Market Score

5 /10

Category Score

0 /10

Market Size

5 /10

64% FI Score
  • bbh
  • ETF
  • Sector Equity
  • Healthcare

VanEck Vectors Biotech ETF

Expenses: 0.35% (Better than 1% of similar funds)

This is an OK choice for a Healthcare Sector Equity fund. See why »

Fund Summary

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Largest Holdings

Amount Holding
12.13% Amgen Inc
8.47% Gilead Sciences, Inc
7.33% Moderna, Inc
6.12% Illumina, Inc
5.46% Regeneron Pharmaceuticals, Inc
5.42% Vertex Pharmaceuticals Incorporated
5.34% Alexion Pharmaceuticals, Inc
5.15% Incyte Corporation
4.66% Biogen Inc
4.57% BioMarin Pharmaceutical Inc

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo